Virus Filtration Market Size to Reach USD 12.3 Billion by 2032 growing at 11.3% CAGR - Exclusive Report by Acumen Research and Consulting

Author: Acumen Research and Consulting

As reported by Acumen Research & Consulting, the global Virus Filtration Market reached USD 4.3 Billion in 2022 and is expected to achieve USD 12.3 Billion by 2032, with a projected CAGR of 11.3% during the forecast period

The virus filtration sector is vital to the safety and purity of biopharmaceutical goods. As the need for biologics like vaccinations, monoclonal antibodies, and gene treatments grows, so does the need for efficient virus filtration technology. Virus filtration is an important step in the bioprocessing of these goods, as it aids in the elimination or reduction of the danger of viral infection. The rising biopharmaceutical sector, increased regulatory scrutiny on product safety, and developments in filtering technology has all contributed to the industry's rapid rise. Companies in this industry are always developing to provide more efficient and robust virus filtration technologies to handle the growing difficulties given by new and existing viruses.

Several factors contribute to the virus filtration industry's growth and dynamism. The use of improved virus filtration procedures is driven by stringent regulatory requirements, particularly in the pharmaceutical and biotechnology sectors. The market is competitive, with significant competitors working on research and development to improve filtering efficiency, throughput, and scalability. Furthermore, the growing worldwide awareness of the necessity of vaccine research, as well as continued efforts to battle infectious illnesses, drive demand for virus filtration technology. The sector is expected to continue growing as a result of continued advances in biopharmaceutical research and production, which ensure the safety and efficacy of therapeutic and preventive drugs.

Virus Filtration Market Value

Virus Filtration Market Statistics

  • The global virus filtration market is poised to reach USD 4.3 billion in sales in 2022
  • Virus filtration market growth is expected to grow with 11.3% CAGR from 2023 to 2032
  • North America dominated the virus filtration market in 2022, holding over 41% of the share
  • Asia-Pacific virus filtration market is projected to grow at a CAGR of over 12% during the same period
  • In terms of product, kits & reagents accounted for 47% of the market in 2022
  • Biological application generated sales of over USD 2.4 billion in 2022
  • Growing focus on personalized medicine acts as a key trend in the virus filtration industry

Request for a sample of this premium research report@

Virus Filtration Market Dynamics

The astounding increase in chronic diseases globally, including cancer, diabetes, and malaria, can be attributed to major factors. Furthermore, the growing awareness of the rise in therapeutics infections caused by viruses, bacteria, and microbes also contributes to the global growth of the virus filtration market. Additionally, the rise in government initiatives, coupled with increased R&D expenses from key players, has resulted in the augmented growth of the virus filtration market. However, the market for virus filtration is likely to face restrictions due to stringent regulations regarding product filtration, particularly in the European region. The consolidated market for product filtration poses another significant challenge for the virus filtration market.

Virus filtration is predominantly employed in pharmaceutical and biological companies due to the rising standards of product processing. It is also used to maintain a pathogen-free work environment. Pathogens such as viruses, bacteria, and microbes can lead to the contamination of water and air, resulting in the development of chronic diseases in employees and degradation in the quality of products.

Increasing Demand for Biopharmaceuticals and Vaccines Fuels the Virus Filtration Market

The virus filtration market is expanding rapidly, owing mostly to rising global demand for biopharmaceuticals and vaccines. As the pharmaceutical industry focuses on developing sophisticated biologics such as monoclonal antibodies, gene treatments, and recombinant proteins, the necessity for strong viral safety precautions becomes critical. Virus filtration is an important step in the production of these biopharmaceuticals, assuring the elimination of any viral contamination that might jeopardize product safety. The rising incidence of chronic illnesses, along with a growing worldwide population, has increased the need for novel and effective biopharmaceutical treatments, propelling the virus filtration market to new heights.

Furthermore, continued attempts to prevent infectious illnesses, such as vaccine development and distribution, contribute considerably to the market's increasing trend. The COVID-19 pandemic's extraordinary worldwide problems have highlighted the need for vaccine development and production. As governments and pharmaceutical corporations work together to address public health concerns, the demand for virus filtration technology has increased to ensure vaccination safety and efficacy. The virus filtration market is expected to expand further as the biopharmaceutical industry develops; highlighting the vital role this sector plays in ensuring the manufacturing of high-quality and safe medicinal goods.

Expansion in Emerging Markets with Increased Healthcare Investments Generate Significant Opportunity in the Virus Filtration Market

The virus filtration market is seeing significant development, owing to the rise of new markets and higher healthcare spending. As emerging nations invest more in healthcare infrastructure and the pharmaceutical and biotechnology sectors, there is a greater demand for improved virus filtration technologies. As emerging markets become more important actors in the global healthcare scene, the demand for strict viral safety precautions in the manufacture of biopharmaceuticals and vaccines grows. The increased emphasis in these areas on healthcare and life sciences creates huge potential for virus filtration market manufacturers to supply cutting-edge solutions and contribute to the safe and efficient manufacturing of biologics.

Furthermore, when governments and corporate organizations in emerging nations engage in improving their healthcare systems, there is a corresponding emphasis on guaranteeing pharmaceutical product quality and safety. Adoption of virus filtration technology aids in satisfying international quality standards and regulatory regulations, allowing for the global export of biopharmaceuticals from these countries. This trend not only boosts virus filtration firms' market presence but also the general resilience and sustainability of healthcare systems in emerging nations. In summary, the growth of emerging countries, along with rising healthcare spending, gives a suitable environment for the virus filtration industry to prosper, providing the growing worldwide need for safe and effective biopharmaceuticals.

Virus Filtration Market Segmentation

The global market for virus filtration has been segmented into product, technology, application, end-user, and region.

  • The product segment split into filtration systems, kits & reagents, services, and other products
  • The technology segment includes filtration (consumables, instruments, and services), and chromatography (consumables, instruments, and services)
  • The application segment covered biological (blood & blood products, vaccines & therapeutics, tissue & tissue products, stem cell products, and cellular & gene therapy products), medical devices, water purification, and air purification
  • Pharmaceutical and biotechnology companies, contract research organization, medical devices companies, and academic institutes & research laboratories segment of the market
  • Finally, the market is segmented by geography, with Asia-Pacific, Latin America, North America, Europe, and the Middle East and Africa (MEA) included

Kits & Reagents to Register Highest Growth Rate during the Forecast Period

The virus filtration market has been segmented into filters and filtration systems, kits and reagents, and services. The kits and reagents segment is anticipated to register the highest CAGR during the forecast period, as they are repeatedly used in various R&D projects, laboratory techniques, and biopharmaceutical companies.

Biological Application to Be the Most Lucrative Segment during the Forecast Period

Based on application, the virus filtration market has been segmented into medical devices, water purification, air purification, and biological. The biological segment, further sub-segmented into blood and blood products, tissue and tissue products, vaccines and therapeutics, cellular and gene therapy products, and stem cell products, accounted for the major share of the virus filtration market in 2022. It is anticipated to be the most attractive segment during the forecast period due to the increasing acceptance of biotherapeutics in biological applications. Biotherapeutics offer reduced adverse effects in biological applications and are therefore extensively employed in various biological applications.

Pharmaceutical & Biotechnology Segment Accounted For Maximum Share in the Virus Filtration Market

Pharmaceutical and biotechnology companies, contract research organizations, and medical device companies are the major end-users of virus filtration. In 2022, the pharmaceutical and biotechnology segment were the major shareholders in the virus filtration market, attributed to the presence of several pharmaceutical and biotechnology companies globally. These companies employ virus filtration to maintain a pathogen-free work environment and uphold high standards of product safety.

Virus Filtration Market Regional Outlook

The virus filtration market has a dynamic geographical view, which is driven by variables such as the prevalence of biopharmaceutical manufacturing, the growth of healthcare infrastructure, and regulatory frameworks. North America is a market leader in virus filtration, owing to the presence of major biopharmaceutical businesses, superior healthcare infrastructure, and a strong regulatory environment. The region's emphasis on R&D, notably in the United States, leads to ongoing innovation and adoption of cutting-edge virus filtration technology.

The virus filtration market in Europe benefits from a well-established pharmaceutical sector as well as strong regulatory regulations that emphasize the importance of product safety. The presence of large biopharmaceutical producers, as well as a rising emphasis on biologics, drives the demand for virus filtration solutions even further. The Asia-Pacific area is seeing rapid expansion, fueled by rising healthcare investments, a growing population, and increased demand for biopharmaceuticals. Countries such as China and India are establishing themselves as major participants in the worldwide virus filtration market, with an emphasis on increasing their biotechnology and pharmaceutical industries.

Latin America the Middle East and Africa are also contributing to market expansion, but at a slower pace. These areas are seeing an increase in healthcare spending and infrastructure development, which is encouraging the use of virus filtration technology as part of attempts to improve pharmaceutical production standards.

Virus Filtration Market Players

Some prominent virus filtration companies covered in the industry include Merck KGaA, General Electric, Lonza, Danaher, WuXiPharmaTech (Cayman) Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, Sartorius AG, and Asahi Kasei Medical Co., Ltd.

Click here to buy the Premium Market Research report

Receive our personalized services and customization by clicking here

Mr. Frank Wilson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533